Skip to main content
. 2016 Oct 15;6:138–142. doi: 10.1016/j.bbacli.2016.10.002

Table 1.

Characteristics of the patients and disease.

Variables n
No. of patients 33
Age (years)
 Median (range) 59 (32–84)
Gender
 Male/female 20/13
Performance status (PS)a
 0/1/2/3 4/19/5/4
Weight lossa
 Yes/no 26/4
Jaundicea
 Yes/no 9/22
Surgery typeb
 Whipple surgery/palliative surgery 5/3
Pathologic tumor (pT) sizea
 < Small (< 40 mm)/≥ large (≥ 40 mm) 14/14
Site of lesion
 Head/corpus-tail 21/10
Response to chemotherapy (CTx)
 Yes (PR + SD)/no (PD) 9/11
Metastasis
 Yes/no 23/10
Erythrocyte sedimentation rate (ESH)
 Normal (< 40/h)/high (> 40/h) 11/12
White blood cell count (WBC)a
 Normal (< 10.000/mm3)/high (> 10.000/mm3) 22/9
Hemoglobin (Hb)a
 Low (< 12 g/dL)/normal (> 12 g/dL) 12/19
Platelet count (PLT)a
 Low (< 150.000/mm3)/normal (> 150.000/mm3) 5/26
Lactate dehydrogenase (LDH)a
 Normal (< 450 IU/L)/high (> 450 IU/L) 21/8
Albumina
 Low (< 4 gr/dL)/normal (> 4 gr/dL) 10/17
Carcinoembryonic antigen (CEA)a
 Normal (< 5 ng/mL)/high (> 5 ng/mL) 19/10
Carbohydrate antigen (CA 19.9)a
 Normal (< 38 U/mL)/high (> 38 U/mL) 7/22
a

Patients with unknown data concerning the variables are not included in the analysis.

b

In 10 patients with non-metastatic disease.